Amber Sani

Preclinical study demonstrating costunolide's neuroprotective effects in a paclitaxel-induced neuropathic pain model using behavioral, spectroscopic (Raman, FTIR), biochemical, and histological analyses; reports improved pain thresholds, preserved neuronal architecture, and modulation of antioxidant and oxidative stress markers.

Integrated network pharmacology, molecular docking, and in vivo pharmacological evaluation showing curzerenone's multi-target effects (MAPK signaling, inflammatory and oxidative markers) and behavioral improvements in a scopolamine-induced amnesia model.

Network pharmacology and in vivo study evaluating terpenoids and coumarins (from Saposhnikovia divaricata) for multitarget modulation of neuroinflammatory and hypoxia-related pathways (including MAPK and HIF-1) with molecular docking and pathway enrichment analyses.